Acceptability of home-use of misoprostol in medical abortion

被引:71
作者
Fiala, C
Winikoff, B
Helström, L
Hellborg, M
Gemzell-Danielsson, K [1 ]
机构
[1] Karolinska Hosp Inst, Div Obstet & Gynaecol, Dept Woman & Child Hlth, S-17176 Stockholm, Sweden
[2] Gynu Hlth Projects, New York, NY 10010 USA
关键词
acceptability; medical abortion; misoprostol; home use; male partner;
D O I
10.1016/j.contraception.2004.06.005
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Introduction: Home-use of misoprostol would reduce the number of visits and improve access to medical abortion. We evaluated acceptance of home-use of misoprostol among women and their partners. Materials and Methods: One hundred women with up to 49 days of amenorrhea were given mifepristone, followed by misoprostol taken at home. Results: Women chose home-use of misoprostol because it felt more natural, private and allowed the presence of a partner/friend. Two women had a vacuum aspiration due to incomplete abortion. Five unscheduled visits occurred. Ninety-six women were satisfied with their choice of home-use. The male partners were generally satisfied with their partner's choice of home-use and felt that their presence and support had been valuable. Discussion: Our study shows a high acceptability among women and their partners and confirms the safety and efficacy of home-use of misoprostol. Women should be offered this choice to allow more flexibility and privacy in their abortions. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:387 / 392
页数:6
相关论文
共 18 条
[1]   Curettage after mifepristone-induced abortion: Frequency, timing, and indications [J].
Allen, RH ;
Westhoff, C ;
De Nonno, L ;
Fielding, SL ;
Schaff, EA .
OBSTETRICS AND GYNECOLOGY, 2001, 98 (01) :101-106
[2]  
*ANES, GUID IND AB 14 WEEKS
[3]  
Aubeny E, 1995, Int J Fertil Menopausal Stud, V40 Suppl 2, P85
[4]   INDUCTION OF ABORTION WITH MIFEPRISTONE (RU-486) AND ORAL OR VAGINAL MISOPROSTOL [J].
ELREFAEY, H ;
RAJASEKAR, D ;
ABDALLA, M ;
CALDER, L ;
TEMPLETON, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (15) :983-987
[5]   Can women in less-developed countries use a simplified medical abortion regimen? [J].
Elul, B ;
Hajri, S ;
Nguyen, TNN ;
Ellertson, C ;
Ben Slama, C ;
Pearlman, E ;
Winikoff, B .
LANCET, 2001, 357 (9266) :1402-1405
[6]   Mifepristone-misoprostol medical abortion: Home administration of misoprostol in Guadeloupe [J].
Guengant, JP ;
Bangou, J ;
Elul, B ;
Ellertson, C .
CONTRACEPTION, 1999, 60 (03) :167-172
[7]   Vaginal misoprostol compared with oral misoprostol in termination of second-trimester pregnancy [J].
Ho, PC ;
Ngai, SW ;
Liu, KL ;
Wong, GCY ;
Lee, SWH .
OBSTETRICS AND GYNECOLOGY, 1997, 90 (05) :735-738
[8]   WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion.: II:: Side effects and women's perceptions [J].
Honkanen, H ;
Piaggio, G ;
von Hertzen, H ;
Bártfai, G ;
Erdenetungalag, R ;
Gemzell-Danielsson, K ;
Gopalan, S ;
Horga, M ;
Jerve, F ;
Mittal, S ;
Ngoc, NTN ;
Peregoudov, A ;
Prasad, RNV ;
Pretnar-Darovec, A ;
Shah, RS ;
Song, S ;
Tang, OS ;
Wu, SC .
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2004, 111 (07) :715-725
[9]   THE EFFECT OF DOSE OF MIFEPRISTONE AND GESTATION ON THE EFFICACY OF MEDICAL ABORTION WITH MIFEPRISTONE AND MISOPROSTOL [J].
MCKINLEY, C ;
THONG, KJ ;
BAIRD, DT .
HUMAN REPRODUCTION, 1993, 8 (09) :1502-1505
[10]  
Schaff EA, 1997, J FAM PRACTICE, V44, P353